Literature: open-access stability study

Quetiapine 10 mg/mL oral suspension

Ingredients

IngredientRoleFor 100 mL
Quetiapine (as fumarate)active1 g
Ora-Blendvehicleq.s. to 100 mL
Strength
10 mg/mL
Starting material
Quetiapine fumarate tablets
Container
Amber plastic bottles
  • Ora-Blend performed better than Ora-Sweet in this study.

Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.

Storage and beyond-use date

StorageBUDBasis
Refrigerated60 daysCited stability study. Duration supported by the cited stability study for this formula, container, and storage.
Room temperature60 daysCited stability study. Duration supported by the cited stability study for this formula, container, and storage.

Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.

Ingredient checks

No FDA compounding list or NIOSH flags for the active ingredient.

Source

Tran J, Gervase MA, Evans J, Deville R, Dong X. The stability of quetiapine oral suspension compounded from commercially available tablets. PLoS One. 2021;16(8):e0255963. PMID 34375349. PMC8354457. License: CC BY (checked 2026-11-06). Read the article · DOI

For licensed clinicians. Use with clinical judgment.